Table of Contents
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.2.1 Markets Covered
1.2.2 Years Considered For The Study
1.3 Currency
1.4 Limitations
1.5 Stakeholders
1.6 Limitations
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.1.1 Approach One: Revenue Mapping-Based Estimation
2.2.1.2 Approach Two: Buyer Adoption-Based Estimation
2.2.2 Top Down Approach: Penetration Rate Based Market Size Estimation
2.2.3 Growth Forecast
2.3 Market Breakdown And Data Triangulation
2.4 Market Player Ranking
2.5 Assumptions For The Study
3 Executive Summary
4 Premium Insights
4.1 Digital Therapeutics Market Overview
4.2 Digital Therapeutics Market, By Sales Channel, 2020–2025
4.3 B2b Sales Channel Market Share, By Buyer & Region (2019)
4.4 Digital Therapeutics Market: Geographic Growth Opportunities
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Incidence Of Preventable Chronic Diseases
5.2.1.2 Rising Focus On Preventive Healthcare
5.2.1.3 Need To Control Healthcare Costs
5.2.1.4 Significant Increase In Venture Capital Investments
5.2.1.5 Benefits Of Digital Therapeutics
5.2.1.5.1 Ability To Induce Behavioral Change
5.2.1.5.2 Improved Drug Adherence
5.2.1.5.3 Patient Convenience And User-Friendliness
5.2.2 Restraints
5.2.2.1 Patient Data Privacy Concerns
5.2.3 Opportunities
5.2.3.1 Emerging Markets
5.2.3.2 Large Undiagnosed And Untreated Population
5.2.3.3 Unexplored Therapeutic Applications
5.2.4 Challenges
5.2.4.1 Unstable Payment Models
5.2.4.2 Reluctance Among Patients To Adopt Digital Therapeutics
5.2.4.3 Lack Of Awareness And Access To Digital Therapeutics Programs In Developing Countries
5.2.4.4 Resistance From Traditional Healthcare Providers
6 Digital Therapeutics Market, By Sales Channel
6.1 Introduction
6.2 B2b
6.2.1 Payers
6.2.1.1 Payers Hold The Highest Share Of The Market, By B2b Sales
6.2.2 Employers
6.2.2.1 Importance Of Employee Health Management Is Propelling The Adoption Of Digital Therapeutics Among Employers
6.2.3 Pharmaceutical Companies
6.2.3.1 Cross-Industry Collaboration Between Digital Therapeutics Start-Ups And Pharmaceutical Companies Will Drive Market Growth
6.2.4 Providers
6.2.4.1 Potential For Better Patient Management And Cost-Reductions Are Driving Demand For Digital Therapeutics Among Providers
6.2.5 Other Buyers
6.3 B2c
6.3.1 Caregivers
6.3.1.1 Ease Of Managing Health Conditions Has Driven Demand For Solutions Among Caregivers
6.3.2 Patients
6.3.2.1 Awareness About Preventive Health Among Patients Will Drive The Growth Of This Segment
7 Digital Therapeutics Market, By Application
7.1 Introduction
7.2 Treatment/Care-Related Applications
7.2.1 Diabetes
7.2.1.1 Growing Prevalence Of Diabetes Drives Market Growth
7.2.2 Central Nervous System Disorders
7.2.2.1 Potential Benefits Of Digital Therapeutics In Cns Disorder Management Have Driven The Development Of Solutions
7.2.3 Smoking Cessation
7.2.3.1 Focus On Providing Clinically Validated, Effective Mobile Applications To Help Quit Smoking Drives Market Growth
7.2.4 Chronic Respiratory Diseases
7.2.4.1 Growing Prevalence Of Copd And Asthma Is Responsible For Market Growth In This Segment
7.2.5 Musculoskeletal Disorders
7.2.5.1 Potential Of Digital Therapeutics In Better Pain Management To Drive The Adoption Of These Solutions Among End Users
7.2.6 Cardiovascular Diseases
7.2.6.1 Increasing Care Cost Of Cvd To Drive The Need For Digital Therapeutics Solutions
7.2.7 Medication Adherence
7.2.7.1 Need To Drive Medication Adherence Rates Have Propelled The Demand For Effective Solutions
7.2.8 Gastrointestinal Disorders
7.2.8.1 Availability Of Mobile Applications For The Management Of Gi Conditions To Drive The Market Growth
7.2.9 Rehabilitation & Patient Care
7.2.9.1 Benefits Of Digital Therapeutics Have Induced Startups To Develop Platforms For Patient Care
7.2.10 Substance Use Disorders & Addiction Management
7.2.10.1 Potential To Improve The Efficiency Of Behavioral Interventions Are Encouraging Market Growth
7.2.11 Other Treatment/Care-Related Applications
7.3 Preventive Applications
7.3.1 Prediabetes
7.3.1.1 Influx Of Startups To Provide Effective Prevention Against Prediabetes Drives The Growth Of This Segment
7.3.2 Obesity
7.3.2.1 Availability Of Cost-Effective Solutions For Obesity Management Propels The Growth Of This Segment
7.3.3 Nutrition
7.3.3.1 Importance Of Nutrition In Preventing A Wide Range Of Ailments Has Driven Demand For Digital Therapeutic Solutions
7.3.4 Lifestyle Management
7.3.4.1 Ability Of Digital Therapeutics Solutions To Induce Positive Behavioral Changes Has Contributed To Rise In Demand
7.3.5 Other Preventive Applications
8 Digital Therapeutics Market, By Region
8.1 Introduction
8.2 North America
8.2.1 Us
8.2.1.1 Major Digital Therapeutics Start-Ups Are Based Out Of The Us, Which Has Greatly Supported Access To Solutions
8.2.2 Canada
8.2.2.1 Efforts Are Being Taken By The Canadian Government To Support Digital Therapeutics
8.3 Europe
8.3.1 Germany
8.3.1.1 Germany Accounted For The Largest Share Of The Digital Therapeutics Market In Europe
8.3.2 Uk
8.3.2.1 Well-Established Healthcare System And Government Support Will Propel The Growth Of The Market
8.3.3 France
8.3.3.1 Growing Healthcare Expenditure And Favorable Health Insurance System To Support Market Growth In France
8.3.4 Spain
8.3.4.1 Initiatives By Emerging Digital Therapeutics Startups Are Supporting Market Growth
8.3.5 Italy
8.3.5.1 Need For Alternative And Effective Treatment To Drive The Market Growth In Coming Years
8.3.6 Rest Of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.1.1 Rising Diabetes Incidence And Collaborations Between Stakeholders Are Indicators Of Market Growth In Japan
8.4.2 China
8.4.2.1 Growing Geriatric Population And Incidence Of Chronic Conditions Will Drive Demand For Digital Therapeutics In China
8.4.3 India
8.4.3.1 Rising Chronic Disease Incidence And The Need For Better Disease Management Drive Market Growth
8.4.4 Rest Of Apac
8.5 Rest Of The World
8.5.1 Rising Burden On Healthcare Systems Drives Demand For Alternative, Cost-Effective Therapies In The Row
9 Competitive Landscape
9.1 Overview
9.2 Market Ranking Analysis, 2019
9.3 Competitive Leadership Mapping
9.3.1 Visionary Leaders
9.3.2 Dynamic Differentiators
9.3.3 Innovators
9.3.4 Emerging Companies
9.4 Competitive Situation And Trends
9.4.1 Product Launches
9.4.2 Expansions
9.4.3 Partnerships, Agreements & Collaborations
10 Company Profiles
10.1 Noom
10.1.1 Business Overview
10.1.2 Products Offered
10.1.3 Recent Developments
10.1.4 Mnm View
10.2 Livongo Health
10.2.1 Business Overview
10.2.2 Products Offered
10.2.3 Recent Developments
10.2.4 Mnm View
10.3 Omada Health
10.3.1 Business Overview
10.3.2 Products Offered
10.3.3 Recent Developments
10.3.4 Mnm View
10.4 Proteus Digital Health
10.4.1 Business Overview
10.4.2 Products Offered
10.4.3 Recent Developments
10.5 Welldoc
10.5.1 Business Overview
10.5.2 Products Offered
10.5.3 Recent Developments
10.6 Ginger
10.6.1 Business Overview
10.6.2 Products Offered
10.7 Propeller Health
10.7.1 Business Overview
10.7.2 Products Offered
10.8 2morrow
10.8.1 Business Overview
10.8.2 Products Offered
10.8.3 Recent Developments
10.9 Canary Health
10.9.1 Business Overview
10.9.2 Products Offered
10.9.3 Recent Developments
10.10 Mango Health Inc.
10.10.1 Business Overview
10.10.2 Products Offered
10.10.3 Recent Developments
10.11 Click Therapeutics
10.11.1 Business Overview
10.11.2 Products Offered
10.11.3 Recent Developments
10.12 Pear Therapeutics
10.12.1 Business Overview
10.12.2 Products & Services Offered
10.12.3 Recent Developments
10.13 Akili Interactive Labs
10.13.1 Business Overview
10.13.2 Products Offered
10.13.3 Recent Developments
10.14 Wellthy Therapeutics
10.14.1 Business Overview
10.14.2 Products Offered
10.14.3 Recent Developments
10.15 Cognoa
10.15.1 Business Overview
10.15.2 Products Offered
10.15.3 Recent Developments
10.16 Happify
10.16.1 Business Overview
10.16.2 Products Offered
10.16.3 Recent Developments
10.17 Kaia Health
10.17.1 Business Overview
10.17.2 Products Offered
10.18 Ayogo Health
10.18.1 Business Overview
10.18.2 Products Offered
10.18.3 Recent Developments
10.19 Better Therapeutics
10.19.1 Business Overview
10.19.2 Products Offered
10.20 Mindstrong Health
10.20.1 Business Overview
10.20.2 Products Offered
11 Appendix
Discussion Guide
11.1 Knowledge Store: Marketsandmarkets’ Subscription Portal
11.2 Available Customizations
11.3 Related Reports
11.4 Author Details
